A
Ascentage Pharma Group International
Q4 2025 earnings expected
Quarter
Oct – Dec
Expected
March 1, 2026(ET)
Revenue
This quarter$48M
Analyst estimate$34M▲ +39.7%
Year ago (Dec '24)$21M▲ +122.3%
EPS
This quarter-$0.99
Analyst estimate$0.02
Year ago (Dec '24)-$1.00▲ +0.9%
Verifying this figure against consensus
Revenue Growth Trajectory
+122%YoY
Last 6 quarters · 1 analysts